课题基金 / 基金详情

Construct of drug delivery system using carbohydrate recognition

Construct of drug delivery system using carbohydrate recognition
利用碳水化合物识别构建药物递送系统
批准号:
14572103
负责人:
TANIMOTO Toshiko
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2005

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Preparation and Characterization of 6^1,6^2-,6^1,6^3-, and 6^1,6^4-Di-O-(α-L-fucopyranosyl)-β- cyclodextrins and Study of Their FunctionsThree positional isomers of 6^1,6^n-di-O-(α-L-fucopyranosyl)-βCDs [6^1,6^n-di-O- (α-L-Fuc)-βCDs, n=2-4] were chemically synthesized by using the authentic compounds, 6^1,6^n-di-O-(tert-butyldimethylsilyl)-βCDs (n=2-4) as the fucosyl intermediates, and the fucosyl donor, 2,3,4-tri-O-acetyl-L-fucopyranosyl trichloroacetimidate. Their structures were analyzed by HPLC, MS, and NMR spectroscopy. The specific interaction between those compounds and fucose-binding lectin AAL (Aleuria aurantia lectin) were investigated by using an optical biosensor. The binding affinity was 6^1,6^4- > 6^1,6^3- > 6^1,6^2-di-O-(α-L-Fuc)-βCD > 6-O-(α-L- Fuc)-βCD in the comparison by the fucose-binding position.2.Synthesis of Novel Heterobranched β-Cyclodextrins Having β-D-N-Acetylglucosaminyl-Maltotriose on the Side ChainGlcNAc-βCD, N-acetylglucosaminyl-β-cyclodextrin ; Gal-Gl … More cNAc-βCD, galactosyl-N-acetyl-glucosaminyl-βCD ; GlcNAc-Glc_3-βCD, N-acetylglucosaminyl-maltotriosyl-βCD ; Gal-GlcNAc-Glc_3-βCD, galactosyl-Nacetylglucosaminyl-maltotriosyl-βCD. From a mixture of N-acetylglucosaminyl-β-cyclodextrin (GlcNAc-βCD) and lactose, β-D-galactosyl-GlcNAc-βCD (Gal-GlcNAc-βCD) was synthesized by the transfer action of β-galactosidase. GlcNAc-maltotriose (Glc_3) and Gal-GlcNAc-Glc_3 were produced with hydrolysis of GlcNAc-βCD by cyclodextrin glycosyltransferase, and Gal-GlcNAc-βCD by bacterial saccharifying α-amylase respectively. Finally, GlcNAc-Glc_3-βCD and Gal-GlcNAc-Glc_3-βCD were synthesized in 5.2% and 3.5% yield when Klebsiella pneumoniae pullulanase was incubated with the mixture of GlcNAc-Glcs and βCD, or Gal-GlcNAc-Glc_3 and βCD respectively. The structures of GlcNAc-Glc_3-βCD and Gal-GlcNAc-Glc_3-βCD were analyzed by FAB-MS and NMR spectroscopy and identified as 6-O-α-(6^3-O-β-D-N-acetylglucosaminyl-malto- triosyl)- βCD, and 6-O-α-(4-O-β-D-galactopyranosyl-6^3-O-β-D-N-acetylglucosaminyl-maltotriosyl)-βCD respectively. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Separation of basic drug enantiomers by capillary electrophoresis using methylated glucuronyl glucosyl β-cyclodextrin as a chiral selector.
使用甲基化葡萄糖醛酸基β-环糊精作为手性选择剂,通过毛细管电泳分离碱性药物对映体。
DOI: --
发表时间: 2002
期刊: Journal of Separation Science 25
影响因子: --
作者: [Toshiko TANIMOTO, Mizue OMATSU, Akiko IKUTA, Yuki NISHI, Hiromi MURAKAMI, Hirofumi NAKANO, Sumio KITAHATA, Akiko Ikuta, Toshiko Tanimoto, Akiko Ikuta, Kazuhiro Yoshinaga, Akiko Ikuta, Kazuhiro Yoshinaga, Toshiko Tanimoto, Hisami Matsunaga]
通讯作者: Hisami Matsunaga
Synthesis of Novel Heterobranched β-Cyclodextrins Having β-D-N-Acetylglucosaminyl-Maltotriose on the Side Chain.
侧链上具有 β-D-N-乙酰葡糖胺基-麦芽三糖的新型异支化 β-环糊精的合成。
DOI: --
发表时间: 2005
期刊: Bioscience Biotechnology Biochemistry 69
影响因子: --
作者: [Toshiko Tanimoto]
通讯作者: Toshiko Tanimoto
Preparation and characterization of 6^1,6^n-di-O-(α-L-fucopyranosyl)-β-cyclodextrins (n=2-4) and study of their functions
6^1,6^n-di-O-(α-L-吡喃岩藻糖基)-β-环糊精(n=2-4)的制备、表征及其功能研究
DOI: --
发表时间: 2004
期刊: Proceedings-12^<th> International Symposium
影响因子: --
作者: [Toshiko TANIMOTO, Mizue OMATSU, Akiko IKUTA, Yuki NISHI, Hiromi MURAKAMI, Hirofumi NAKANO, Sumio KITAHATA, Akiko Ikuta, Toshiko Tanimoto]
通讯作者: Toshiko Tanimoto
Sunthesis of Novel Heterobranched β-Cyclodextrins Having β-D-N-Acetylglucosaminyl-Maltotriose on the Side Chain.
侧链上具有 β-D-N-乙酰葡糖胺基-麦芽三糖的新型异支化 β-环糊精的合成。
DOI: --
发表时间: 2005
期刊: Bioscience Biotechnology Biochemistry 69
影响因子: --
作者: [Toshiko Tanimoto]
通讯作者: Toshiko Tanimoto
14
    国内基金
    海外基金
    L-fucose调控肠道菌群与ILC3互作缓解肠道炎症
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2022
    • 负责人:
    • 依托单位: